PhiChem Corporation
300398.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.60 | -1.54 | 0.10 | -0.97 |
| FCF Yield | 0.66% | -0.32% | -0.32% | 1.15% |
| EV / EBITDA | 136.35 | 58.89 | 43.19 | 82.25 |
| Quality | ||||
| ROIC | 1.59% | 1.75% | 2.17% | 0.86% |
| Gross Margin | 36.25% | 36.99% | 35.11% | 30.60% |
| Cash Conversion Ratio | 2.10 | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 5.03% | 5.04% | 3.73% | 0.12% |
| Free Cash Flow Growth | 398.12% | -11.97% | -130.98% | -30.71% |
| Safety | ||||
| Net Debt / EBITDA | 0.04 | -1.38 | 1.22 | 3.52 |
| Interest Coverage | 20.69 | 13.50 | 13.35 | 13.18 |
| Efficiency | ||||
| Inventory Turnover | 0.82 | 0.69 | 0.69 | 0.78 |
| Cash Conversion Cycle | 180.16 | 182.01 | 190.98 | 174.40 |